These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 18448571)

  • 21. Characterization of sirolimus metabolites in pediatric solid organ transplant recipients.
    Filler G; Bendrick-Peart J; Strom T; Zhang YL; Johnson G; Christians U
    Pediatr Transplant; 2009 Feb; 13(1):44-53. PubMed ID: 18482220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Everolimus-related pulmonary toxicity in heart transplant recipients.
    Expósito V; de Prada JA; Gómez-Román JJ; González-Vilchez F; Llano-Cardenal M; García-Camarero T; Fernández-Valls M; Ruano J; Martín-Durán R
    J Heart Lung Transplant; 2008 Jul; 27(7):797-800. PubMed ID: 18582812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of in-vivo and in-vitro metabolites of palmatine by liquid chromatography-tandem mass spectrometry.
    Yang QC; Wu WH; Han FM; Chen Y
    J Pharm Pharmacol; 2009 May; 61(5):647-52. PubMed ID: 19406004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral everolimus inhibits neointimal proliferation in prosthetic pulmonary valved stents in pigs.
    Kuehne T; Pietzner K; Lehmkuhl HB; Gelernter D; Peters B; Krueger JJ; Meinus C; Klimes K; Brinkert F; Ewert P; Berger F
    J Heart Valve Dis; 2008 Jul; 17(4):465-72. PubMed ID: 18751477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography-mass spectrometry.
    van der Heijden J; de Beer Y; Hoogtanders K; Christiaans M; de Jong GJ; Neef C; Stolk L
    J Pharm Biomed Anal; 2009 Nov; 50(4):664-70. PubMed ID: 19155152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolite identification of a new antitumor agent icotinib in rats using liquid chromatography/tandem mass spectrometry.
    Guan Z; Chen X; Wang Y; Zhong D
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2176-84. PubMed ID: 18536068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effect of omega-3 fatty acids on sirolimus- or everolimus-induced hypertriglyceridemia in heart transplant recipients.
    Celik S; Doesch A; Erbel C; Blessing E; Ammon K; Koch A; Katus HA; Dengler TJ
    Transplantation; 2008 Jul; 86(2):245-50. PubMed ID: 18645486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation of an immunosuppressive metabolite of FK506 generated by human microsome preparations.
    Christians U; Radeke HH; Kownatzki R; Schiebel HM; Schottmann R; Sewing KF
    Clin Biochem; 1991 Jun; 24(3):271-5. PubMed ID: 1714802
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolongation of corneal allograft survival by topical application of everolimus in experimental keratoplasty.
    Li XQ; Buch G; Otasevic L; Schlickeiser S; Bertelmann E; Pleyer U
    Ophthalmic Res; 2008 Oct; 40(6):309-14. PubMed ID: 18688173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of pre-rapamycin, the first macrocyclic intermediate in the biosynthesis of the immunosuppressant rapamycin by S. hygroscopicus.
    Gregory MA; Gaisser S; Lill RE; Hong H; Sheridan RM; Wilkinson B; Petkovic H; Weston AJ; Carletti I; Lee HL; Staunton J; Leadlay PF
    Angew Chem Int Ed Engl; 2004 May; 43(19):2551-3. PubMed ID: 15127450
    [No Abstract]   [Full Text] [Related]  

  • 31. Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay.
    Bouzas L; Tutor JC
    Clin Biochem; 2007 Jan; 40(1-2):132-6. PubMed ID: 17011541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Everolimus (RAD001): an mTOR inhibitor for the treatment of metastatic renal cell carcinoma.
    Oudard S; Medioni J; Aylllon J; Barrascourt E; Elaidi RT; Balcaceres J; Scotte F
    Expert Rev Anticancer Ther; 2009 Jun; 9(6):705-17. PubMed ID: 19496707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts.
    Semsroth S; Stigler RG; Bernecker OY; Ruttmann-Ulmer E; Troppmair J; Macfelda K; Bonatti JO; Laufer G
    Eur J Cardiothorac Surg; 2009 Mar; 35(3):515-20. PubMed ID: 19167904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTOR inhibitor everolimus ameliorates progressive tubular dysfunction in chronic renal failure rats.
    Nakagawa S; Masuda S; Nishihara K; Inui K
    Biochem Pharmacol; 2010 Jan; 79(1):67-76. PubMed ID: 19660439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultra-performance hydrophilic interaction liquid chromatography/tandem mass spectrometry for the determination of everolimus in mouse plasma.
    Hsieh Y; Galviz G; Long BJ
    Rapid Commun Mass Spectrom; 2009 May; 23(10):1461-6. PubMed ID: 19350527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo and in vitro metabolism of lefucoxib in rats.
    Bi X; Meng Z; Chen H; Zhu X; Dou G
    J Pharm Biomed Anal; 2008 Sep; 48(1):134-9. PubMed ID: 18538525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic interaction between everolimus and antifungal triazoles in a liver transplant patient.
    Pea F; Baccarani U; Tavio M; Cojutti P; Adani GL; Londero A; Baraldo M; Franceschi L; Furlanut M; Viale P
    Ann Pharmacother; 2008 Nov; 42(11):1711-6. PubMed ID: 18812562
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirolimus: a new immunosuppressant.
    Mukherjee T; Shah BV
    J Assoc Physicians India; 2005 Oct; 53():885-90. PubMed ID: 16459533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of metabolites of tectoridin in-vivo and in-vitro by liquid chromatography-tandem mass spectrometry.
    Chen Y; Song W; Peng ZH; Ge BY; Han FM
    J Pharm Pharmacol; 2008 Jun; 60(6):709-16. PubMed ID: 18498706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Everolimus with reduced-dose cyclosporine in de novo renal transplant recipients: Philippine experience.
    Li JT; Danguilan RA; Cabanayan-Casasola CB; Talusan-Tomacruz Y; Ona ET
    Transplant Proc; 2008 Sep; 40(7):2211-3. PubMed ID: 18790195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.